Approval of 2nd Generation BTK-Inhibitor Acalabrutinib CALQUENCE (R): Optimizing CLL-Therapy

Arnheim, K

ONCOLOGY RESEARCH AND TREATMENT, 2021; 44 (1-2): 60

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索